Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 2/20 | 0.38 |
| ▸ | GABRD | O14764 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.38 |
| ▸ | GABRE | P78334 | 2/20 | 0.38 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1074666 | 1.00 | ALOX15 (0.42) | ALOX15ALDH1A1MEN1NPC1KMT2A | |
| Hydrochloric Acid SCHEMBL4100969 | 0.98 | ALOX15 (0.41) | ALOX15ALDH1A1MEN1NPC1KMT2A | |
| Hydrochloric Acid SCHEMBL9076573 | 0.98 | ALOX15 (0.41) | ALOX15ALDH1A1MEN1NPC1KMT2A | |
| SCHEMBL16098107 | 0.84 | NOD1 (0.43) | ALDH1A1NOD1 | |
| SCHEMBL14016339 | 0.83 | ALOX15 (0.48) | ALOX15ALDH1A1LMNAHSD17B10GRIK1 | |
| SCHEMBL1075213 | 0.83 | HCAR2 (0.39) | ALDH1A1LMNAGRIK1HCAR2NOD1 | |
| SCHEMBL28232296 | 0.83 | ALOX15 (0.44) | ALOX15ALDH1A1MEN1NPC1KMT2A | |
| SCHEMBL1075212 | 0.83 | HCAR2 (0.39) | ALDH1A1LMNAGRIK1HCAR2NOD1 | |
| SCHEMBL1172849 | 0.82 | MGAM (0.48) | ALOX15ALDH1A1KMT2ALMNAHSD17B10 | |
| SCHEMBL2617390 | 0.82 | MGAM (0.48) | ALOX15ALDH1A1KMT2ALMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905527-B2 | Gel composition for culturing cells, production method thereof, method for culturing cells, and substrate for culturing cells | SHIMADZU CORPORATION (JP) | 2024-02-20 | — | — | US | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| CN-104937041-B | Method for preparing self-dispersing pigment | 纳幕尔杜邦公司 | 2017-10-27 | — | — | CN | claimed |
| CN-104919008-B | Method for preparing the silica containing self-dispersing pigment of bag | 纳幕尔杜邦公司 | 2017-07-18 | — | — | CN | claimed |
| US-5250517-A | Hypotensive and cardiotonic agents; cardiac insufficiency | HOFFMANN-LA ROCHE INC. (US) | 1993-10-05 | — | — | US | claimed |
| CN-120040435-A | Mangiferin and derivatives thereof, preparation method and medical application thereof | 安徽中医药大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20250035616-A1 | Organoid Compositions | SHIMADZU CORPORATION (JP) | 2025-01-30 | — | — | US | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-4393937-A1 | STEROID COMPOUND AND CONJUGATE THEREOF | Duality Biologics (Suzhou) Co., Ltd. (CN) | 2024-07-03 | — | — | EP | disclosed |
| CN-115304516-B | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2024-04-30 | — | — | CN | disclosed |
| US-11905527-B2 | Gel composition for culturing cells, production method thereof, method for culturing cells, and substrate for culturing cells | SHIMADZU CORPORATION (JP) | 2024-02-20 | — | — | US | disclosed |
| US-20230406884-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ZEALAND PHARMA A/S (DK) | 2023-12-21 | — | — | US | disclosed |
| WO-1998029419-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998029422-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| EP-0801644-A1 | POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5556990-A | SQUALENE SYNTHASE INHIBITORS, ANTICHOLESTEROL AGENTS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-09-17 | — | — | US | disclosed |
| WO-1996018615-A1 | POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5278148-A | Hypotensive agents | HOFFMANN-LA ROCHE INC. (US) | 1994-01-11 | — | — | US | disclosed |
| US-5250517-A | Hypotensive and cardiotonic agents; cardiac insufficiency | HOFFMANN-LA ROCHE INC. (US) | 1993-10-05 | — | — | US | disclosed |
| US-5140011-A | Hypotensive agents | HOFFMANN-LA ROCHE, INC. (US) | 1992-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406884-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ITGB7, ITGB4, ITGA4 | ALOX15 4660/4885ALDH1A1 2543/4885MEN1 1248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.